-
-
-
Ki-Suck Jung
President, APSR 2022
Local Congress Committee
Professor, Hallym University College of Medicine -
Jae Jeong Shim
Secretary General, APSR 2022
Local Congress Committee
Professor, Korea University College of Medicine -
Jang-Won Sohn
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Hanyang University College of Medicine -
Kwang Ha Yoo
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Konkuk University School of Medicine -
Chin Kook Rhee
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, The Catholic University of Korea College of Medicine
-
Speaker's Highlight
-
-
Don Sin
University of British Columbia, St. Paul Hospital (Canada)
Kenneth R. Chapman
Toronto General Hospital Research Institute (Canada)
-
Parameswaran Nair
McMaster University (Canada)
Carolyn Calfee
UCSF (U.S.A.)
-
Gregory P. Downey
University of Colorado School of Medicine (U.S.A.)
David A. Schwartz
University of Colorado School of Medicine (U.S.A.)
-
Neil Schluger
Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
Nick Kim
Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
-
Nicola Hananiah
Baylor College of Medicine (U.S.A.)
Jae-Joon Yim
Seoul National University College of Medicine (Republic of Korea)
-
Koichiro Asano
Tokai University School of Medicine (Japan)
Diahn-Warng Perng
Taipei Veterans General Hospital (Taiwan)
-
Konstantinos Kostikas
University of Ioannina (Greece)
Karin Klooster
University Medical Center Groningen (Kingdom of the Netherlands)
-
Air pollution and acute exacerbations of IPF
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease marked by stiff lungs, impaired gas transfer and declining exercise tolerance. An acute exacerbation brings sudden breathlessness, cough, hypoxaemia and new imaging abnormalities, with infection, aspiration, embolism, fluid overload and other diagnoses considered before an environmental cause is assigned.
Air pollution is a modifiable exposure embedded in daily life, from traffic exhaust to wood-heater smoke and regional fire plumes. This makes the association between air pollution and acute exacerbations of idiopathic pulmonary fibrosis clinically important, particularly when pollution peaks coincide with respiratory infections or background lung disease.
Evidence is largely observational and should be interpreted as increased risk rather than proof that pollution caused an individual event. Season, geography, indoor conditions, disease severity and co-existing illness influence both measured exposure and outcomes.
Acute exacerbations and their clinical footprint
IPF usually follows a slow decline, but acute events can disrupt that trajectory through severe breathlessness, reduced oxygen saturation and widespread new opacities on imaging. Hospital admission is often required, and the short-term mortality associated with an acute exacerbation is substantial, especially in people with advanced fibrosis or impaired lung function.
Exacerbations are heterogeneous. Infection, aspiration, pulmonary embolism, pneumothorax, heart failure and medication effects may resemble one another, while the timing of symptoms can provide a clue to an acute inhaled irritant. Pollution may also increase vulnerability to infection, making attribution to a single cause difficult.
Pollutants and pathways to lung injury
Fine particulate matter, especially PM2.5, can penetrate deep into the lungs and reach the alveolar region, where it may trigger oxidative stress, epithelial injury and inflammatory signalling. Repeated exposure could impair repair in already abnormal lung tissue and increase susceptibility to infection. The relevant dose includes both the concentration of particles and the length of time they are encountered.
Nitrogen dioxide, often used as an indicator of traffic-related pollution, can injure airway epithelium and promote inflammation. Ozone, sulphur dioxide and traffic-related mixtures may add to this burden, while ultrafine particles and combustion products can accompany busy roads, ports and indoor smoke. Pollutants often occur together, so an observed effect may represent a mixture rather than one chemical.
What the observational evidence shows
Cohort and time-series studies generally report associations between higher ambient particulate or traffic-related pollution and more frequent acute respiratory deterioration in IPF. Some research also links long-term exposure with greater disease burden and poorer prognosis. These patterns support biological plausibility, although results vary with study design, location and how exacerbations are identified.
Most studies use nearby monitoring stations, satellite estimates, land-use models or hospital-admission data to represent individual exposure. These methods can miss time at home, indoor infiltration and personal activity. There is also no single universal safe threshold for people with fibrotic lung disease, so individual risk may rise before general population warnings identify a severe event.
Bushfire smoke, wood heating and seasonal exposure
Wildfire smoke is Australia’s most intense episodic pollution exposure. During the 2019–20 Black Summer fires, smoke travelled thousands of kilometres and blanketed Sydney and Melbourne, forcing many people to remain indoors for extended periods. For people with IPF, such events can produce a sharp increase in cough, breathlessness and fatigue, even when visible haze appears moderate.
Everyday domestic combustion adds a different pattern. Wood heaters are common in Melbourne’s cooler suburbs and nearby regional towns, and smoke can enter homes through open windows, vents and gaps. Burning household timber during a cold snap may raise indoor particles at the same time as outdoor traffic pollution; portable filters and effective ventilation can reduce this indoor contribution.
City, market and policy differences
Australian exposure profiles vary markedly. Sydney combines dense road traffic, port and freight activity with episodic fire smoke; Melbourne has heavy road traffic, shipping around Port Phillip and seasonal wood-heater emissions. Brisbane can experience high ozone during hot, humid summer conditions, while Perth’s cool-season inversions can trap road, port and mining-related pollution near the ground.
These patterns sit within a distinct local emissions market: diesel freight, coal exports through ports such as Newcastle, Port Hedland and Gladstone, and construction or farming dust can affect air quality beyond the immediate city. Australia’s National Clean Air Strategy and National Ambient Air Quality Standards provide a national framework, while state agencies such as the NSW Environment Protection Authority and Victoria’s EPA oversee emission rules, wood-heater programs and burning restrictions.
Separating pollution from other causes
During an acute deterioration, clinicians should assess the patient rather than assume an environmental explanation. Relevant checks include oxygen saturation, imaging, infection testing and evaluation for embolic disease, fluid overload, aspiration or cardiac complications. A pollution spike can support context, but it does not remove the need to exclude treatable clinical causes.
Respiratory symptoms may also arise from several diseases at once. In systemic sclerosis, for example, reflux and aspiration associated with esophageal motility disorders can complicate the interpretation of cough and breathlessness. Such overlap reinforces the need for careful phenotyping before labelling a change as an IPF exacerbation.
Recording location, recent travel, outdoor activity, smoke exposure, household heating and the timing of symptom onset can make subsequent assessment more precise. Routine linkage with local air-quality indices and smoke warnings may help identify clusters, while prospective studies are needed to establish stronger individual-level estimates of risk.
Practical implications for respiratory care
Care plans can incorporate high-pollution days without allowing air quality to eclipse infection control, vaccination, exercise rehabilitation and prescribed antifibrotic treatment. Inhaled corticosteroid use should follow established clinical indications rather than being changed solely because outdoor pollution rises. Patients who develop sudden deterioration need prompt clinical review, including oxygen assessment and investigation for infection or other complications.
Practical measures include closing windows during heavy outdoor pollution, using suitable HEPA filtration, reducing exertion near high-traffic roads during peak exposure and following official smoke advisories. Clinicians can also ask about occupational exposure and household heating, which may reveal modifiable risks overlooked in a brief consultation.
For Australian respiratory services, the practical takeaway is to treat ambient air quality as a short-term risk variable: capture it in clinical records, pair it with pollution alerts and patient education, and ensure that any sudden decline in an IPF patient receives early assessment and escalation, rather than being dismissed as pollution alone.
Richard Russell
Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
-
Mona Bafadhel
King’s College London (United Kingdom)
David Jackson
Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
-
James Chalmers
University of Dundee (United Kingdom)
David Price
University of Aberdeen (United Kingdom)
-